Industry reports
Editor highlights

World Ophthalmic Pharmaceutical Drugs Market

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Sandoz International GmbH SWOT Analysis, Strategy, Revenues and Profits

Sandoz International GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Generic Drug | Countries: Germany, India, Argentina, Brazil, Canada, Slovenia, Poland, Austria

PHOENIX Group SWOT Analysis, Strategy, Revenues and Profits

PHOENIX Group SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pharmacies and Drug Stores | Countries: Europe, Czech Republic, Germany, Sweden, Slovakia (slovak Republic), Italy, Finland, Denmark, Bulgaria, World, Switzerland, Netherlands, Norway, Hungary, Croatia, Bosnia and Herzegovina, Serbia and Montenegro

Andreae-Noris Zahn AG (Symbol:ANZ) SWOT Analysis, Strategy, Revenues and Profits

Andreae-Noris Zahn AG (Symbol:ANZ) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Andreae-Noris Zahn AG SWOT Analysis report provides you a strategic ...

Industries: Generic Drug | Countries: Germany

biolitec AG (Symbol:BIB) SWOT Analysis, Strategy, Revenues and Profits

biolitec AG (Symbol:BIB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. biolitec AG SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: Germany, United States, Spain, Russian Federation, Italy

Recordati S.p.A. (Symbol:REC) SWOT Analysis, Strategy, Revenues and Profits

Recordati S.p.A. (Symbol:REC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Recordati S.p.A. SWOT Analysis report provides you a strategic analysis ...

Industries: Pharmaceutical | Countries: Czech Republic, Germany, Europe

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

  • $ 3 500
  • Industry report
  • by GBI Research
  • April 2014
  • 122 pages

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading business intelligence provider, has released its latest research,‘Pancreatic Adenocarcinoma Therapeutics ...

Industries: Therapy | Countries: World, Japan, Canada, Europe, United States, Spain, Italy, France, Germany, United Kingdom, North America

Clinical Trial Management System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019

Clinical Trial Management System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019

  • $ 4 795
  • Industry report
  • by Transparency Market Research
  • April 2014
  • 113 pages

Clinical trial management system (CTMS) is a software solution for proper management, storage and analysis of drugs associated clinical data. CTMS is primarily employed to manage large amount of data involved in a clinical trial including planning, preparation and reporting. CTMS also provides data to ...

Industries: Drug Discovery and Development | Countries: World, United States, South Korea, Europe, Asia, Poland, France, Germany, China

EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023

EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • by Global Data
  • April 2014
  • 49 pages

EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023 Summary Allergic rhinitis is a chronic respiratory disease characterized by inflammation of the nasal cavity and affects people of all ages. The main symptoms of allergic rhinitis are sneezing, nasal itching, blocked or runny nose and ...

Industries: Pathology | Countries: Japan, World, Spain, Italy, France, Germany, United States, United Kingdom

PharmaPoint: Migraine - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Migraine - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • by Global Data
  • March 2014
  • 149 pages

PharmaPoint: Migraine - 5EU Drug Forecast and Market Analysis to 2023 Summary The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which ...

Industries: Pathology | Countries: Spain, Italy, Germany, France, Europe, United Kingdom

World Therapy: Alopecia – Pipeline Review, H1 2012

World Therapy: Alopecia – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • March 2014
  • 80 pages

This report provides data on the therapeutic development for Alopecia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Alopecia. 'Alopecia - Pipeline Review, H1 2012' is built using data ...

Industries: Pathology | Countries: World, Germany

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 917 267 7886

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.